RLBD (RLBD) Stock Price & Analysis
RLBD (RLBD) rose 0.00% to USD 0 as of July 25, 2026 at 12:38 UTC, according to Nexqual real-time market data.
RLBD last closed at USD 0; the session ranged USD 0–0 on volume of 1,009,100 shares. Market capitalization is $26,906, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, July 25, 2026 at 12:38 UTC.
Key Statistics (as of July 25, 2026 at 12:38 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1,009,100 shares |
| Market Cap | $26,906 |
| Exchange | PNK |
Technical Analysis (RLBD)
Nexqual's technical model rates RLBD "SELL" based on 0 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 12:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (RLBD)
Wall Street analysts rate RLBD "None", per Nexqual as of July 25, 2026 at 12:38 UTC.
| Consensus Rating | None |
|---|
Earnings (RLBD)
Source: Nexqual, July 25, 2026 at 12:38 UTC.
Financials & Fundamentals (RLBD)
| Total Revenue | $38,206 |
|---|---|
| Gross Margin | -76.96% |
| Operating Margin | -1747.53% |
| Profit Margin | +0.00% |
| Current Ratio | 0.01 |
| Total Cash | $22,422 |
| Total Debt | $1.05M |
| Free Cash Flow | $150,024 |
Source: Nexqual, July 25, 2026 at 12:38 UTC.
Financial Health Score (RLBD)
Nexqual rates RLBD's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 12:38 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $22K cash vs $1M debt |
| Cash Flow | Strong — FCF $150K, 393% margin |
| Efficiency | Mixed — No data |
Ownership (RLBD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.69B |
| Float | 934.43M |
Source: Nexqual, July 25, 2026 at 12:38 UTC.
Leadership (RLBD)
RLBD is led by Christopher J. Ryan (age 64), VP of Finance, Principal Accounting Officer, CFO, Secretary & Treasurer, per Nexqual as of July 25, 2026 at 12:38 UTC.
| VP of Finance, Principal Accounting Officer, CFO, Secretary & Treasurer | Christopher J. Ryan (age 64) |
|---|---|
| Chief Scientific Officer | Adel Rammal |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HIPH | American Premium Water Corporat | USD 0 | ▲ 0% |
| PURA | Puration Inc. | USD 0 | ▲ 0% |
| EVHO | Evercore Holdings, Inc. | USD 0.01 | ▲ 15.56% |
| KALY | KALI INC | USD 0 | ▲ 0% |
| NOUV | Nouveau Life Pharmaceuticals, I | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 12:38 UTC. This page is informational and not investment advice.